AQR Arbitrage’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
MF
WAM
LP
TCM
KIM
PAMP
AIMCA
LA
RCM
AQR Arbitrage's TDAC Position: Q1 2026 in Review
AQR Arbitrage reduced its Translational Development Acquisition Corp (TDAC) stake by 0.25% in Q1 2026, selling an estimated $29.3K and leaving 1,094,210 shares worth $11.6M. The position accounts for 0.19% of the portfolio, ranked #116.
AQR Arbitrage first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.
- AQR Arbitrage held 1,094,210 shares of Translational Development Acquisition Corp worth $11.6M as of Q1 2026.
- AQR Arbitrage sold 2,779 Translational Development Acquisition Corp shares in Q1 2026, an estimated $29.3K.
- Translational Development Acquisition Corp made up 0.19% of AQR Arbitrage's portfolio in Q1 2026, its #116 holding.
- AQR Arbitrage first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
- 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.
Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.